Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Paradigm Biopharmaceuticals Limited PBIGF

Full chart Compare
Set alert

Price alert · PBIGF

All alert types
0.01 USD 0.00 (+0.00%)

At closeNov 3, 2026, 4:00 PM EST

0.008 Day range 0.008
0.0014 52-week range 0.2859
YTD
-94.87%
1 year
-95.44%

Financial health

Altman Z-Score

-19.48 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C-1 / 5 overall

  • DCF 4
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -1.2×
FY 2017: -32.3×FY 2018: -27.5×FY 2019: -13.2×FY 2020: -58.6×FY 2021: -14.1×FY 2022: -6.1×FY 2023: -5.2×FY 2024: -1.4×FY 2025: -5.5×FY 2026: -1.2×
FY 2017 5y median -5.2× FY 2026
P/S 883×
FY 2017: 75.8×FY 2018: 63.6×FY 2019: 69.5×FY 2020: 0.0×FY 2021: 23260×FY 2022: 2945×FY 2023: 5839×FY 2024: 1268×FY 2025: 1986×FY 2026: 883×
FY 2017 5y median 1986× FY 2026
P/B 20.4×
FY 2017: 10.3×FY 2018: 12.3×FY 2019: 2.5×FY 2020: 6.7×FY 2021: 6.1×FY 2022: 5.5×FY 2023: 5.1×FY 2024: 3.5×FY 2025: 4.9×FY 2026: 20.4×
FY 2017 5y median 5.1× FY 2026
P/FCF -1.6×
FY 2017: -30.8×FY 2018: -28.3×FY 2019: -32.5×FY 2020: -70.5×FY 2021: -13.7×FY 2022: -7.2×FY 2023: -6.0×FY 2024: -1.3×FY 2025: -6.5×FY 2026: -1.6×
FY 2017 5y median -6.0× FY 2026
EV/EBITDA -1.0×
FY 2017: -22.1×FY 2018: -18.8×FY 2019: -14.4×FY 2020: -39.4×FY 2021: -9.5×FY 2022: -4.2×FY 2023: -3.6×FY 2024: -1.0×FY 2025: -3.4×FY 2026: -1.0×
FY 2017 5y median -3.4× FY 2026
EV/Sales 784×
FY 2017: 74.4×FY 2018: 62.7×FY 2019: 43.1×FY 2020: 0.0×FY 2021: 19839×FY 2022: 2452×FY 2023: 4642×FY 2024: 1001×FY 2025: 1663×FY 2026: 784×
FY 2017 5y median 1663× FY 2026
FCF Yield -61.8%
FY 2017: -3.2%FY 2018: -3.5%FY 2019: -3.1%FY 2020: -1.4%FY 2021: -7.3%FY 2022: -13.8%FY 2023: -16.5%FY 2024: -79.0%FY 2025: -15.5%FY 2026: -61.8%
FY 2017 5y median -16.5% FY 2026

Profitability

Gross Margin -102.8%
FY 2017: 99.1%FY 2018: 99.4%FY 2019: 99.7%FY 2020: 0.0%FY 2021: -382.4%FY 2022: -81.4%FY 2023: 59.7%FY 2024: 86.3%FY 2025: -38.2%FY 2026: -102.8%
FY 2017 5y median -38.2% FY 2026
Operating Margin -76248.1%
FY 2017: -335.9%FY 2018: -332.7%FY 2019: -293.1%FY 2020: 0.0%FY 2021: -210124.4%FY 2022: -60498.8%FY 2023: -128497.1%FY 2024: -99077.5%FY 2025: -43910.6%FY 2026: -76248.1%
FY 2017 5y median -76248.1% FY 2026
Net Margin -70283.8%
FY 2017: -234.5%FY 2018: -230.7%FY 2019: -523.7%FY 2020: 0.0%FY 2021: -166895.4%FY 2022: -49543.1%FY 2023: -111013.7%FY 2024: -89138.3%FY 2025: -36014.5%FY 2026: -70283.8%
FY 2017 5y median -70283.8% FY 2026
ROE -1623.0%
FY 2017: -31.9%FY 2018: -44.6%FY 2019: -18.9%FY 2020: -11.4%FY 2021: -43.8%FY 2022: -92.8%FY 2023: -96.7%FY 2024: -246.4%FY 2025: -88.6%FY 2026: -1623.0%
FY 2017 5y median -96.7% FY 2026
ROIC -484.1%
FY 2017: -32.1%FY 2018: -44.8%FY 2019: -8.9%FY 2020: -12.0%FY 2021: -43.9%FY 2022: -93.0%FY 2023: -97.7%FY 2024: -269.9%FY 2025: -79.5%FY 2026: -484.1%
FY 2017 5y median -97.7% FY 2026
ROA -184.4%
FY 2017: -29.8%FY 2018: -40.7%FY 2019: -18.3%FY 2020: -10.9%FY 2021: -40.4%FY 2022: -77.4%FY 2023: -77.4%FY 2024: -214.1%FY 2025: -76.4%FY 2026: -184.4%
FY 2017 5y median -77.4% FY 2026

Growth (YoY)

Revenue 53.6%
FY 2017: 0.0%FY 2018: 47.2%FY 2019: 11.2%FY 2020: -100.0%FY 2021: 0.0%FY 2022: 285.5%FY 2023: -41.0%FY 2024: 40.7%FY 2025: -20.8%FY 2026: 53.6%
FY 2017 FY 2026
Operating Income -166.6%
FY 2017: -41.8%FY 2018: -45.8%FY 2019: 2.0%FY 2020: -93.9%FY 2021: -154.6%FY 2022: -11.0%FY 2023: -25.4%FY 2024: -8.5%FY 2025: 64.9%FY 2026: -166.6%
FY 2017 FY 2026
EPS (diluted) -168.0%
FY 2017: -24.5%FY 2018: -22.0%FY 2019: -113.6%FY 2020: 46.3%FY 2021: -170.7%FY 2022: 0.0%FY 2023: -12.5%FY 2024: -11.1%FY 2025: 70.2%FY 2026: -168.0%
FY 2017 FY 2026
Free Cash Flow -172.8%
FY 2017: -24.7%FY 2018: -34.0%FY 2019: -6.1%FY 2020: -60.1%FY 2021: -242.1%FY 2022: 7.9%FY 2023: -40.3%FY 2024: -45.9%FY 2025: 75.7%FY 2026: -172.8%
FY 2017 FY 2026

Financial Health

Current Ratio 1.1×
FY 2017: 4.6×FY 2018: 4.0×FY 2019: 30.5×FY 2020: 32.2×FY 2021: 14.0×FY 2022: 6.0×FY 2023: 4.9×FY 2024: 7.2×FY 2025: 7.5×FY 2026: 1.1×
FY 2017 5y median 6.0× FY 2026
Quick Ratio 1.1×
FY 2017: 6.5×FY 2018: 6.0×FY 2019: 31.8×FY 2020: 32.2×FY 2021: 14.0×FY 2022: 6.0×FY 2023: 4.9×FY 2024: 7.2×FY 2025: 7.5×FY 2026: 1.1×
FY 2017 5y median 6.0× FY 2026
Debt / Equity 2.2×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 2.2×
FY 2017 5y median 0.0× FY 2026
Net Debt / EBITDA 0.1×
FY 2017: 0.4×FY 2018: 0.3×FY 2019: 8.8×FY 2020: 6.6×FY 2021: 1.6×FY 2022: 0.8×FY 2023: 0.9×FY 2024: 0.3×FY 2025: 0.7×FY 2026: 0.1×
FY 2017 5y median 0.7× FY 2026
Interest Coverage -24.8×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -496×FY 2021: -1145×FY 2022: -1674×FY 2023: -3660×FY 2024: -4537×FY 2025: -3232×FY 2026: -24.8×
FY 2017 5y median -3232× FY 2026

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026

Annual · latest fiscal year ends 2026-06-30